Akzo sticking with IPO plan for Organon sale

25 January 2007 11:42  [Source: ICIS news]

LONDON (ICIS news)--Akzo Nobel is sticking to its plan to divest its pharmaceutical business Organon through an initial public offering (IPO) after rejecting recent proposals from private equity firms to buy the unit as a whole, the company said on Thursday.

 

Akzo said it had reviewed the offers from the perspective of long-term shareholder value creation but had decided not to divert resources away from pursuing the Organon listing within the original planned timeline of early 2007.

 

The company hopes to list 20-30% of Organon shares.

 

There had been earlier speculation that a sale to private equity might help fund a potential acquisition of ICI.  

 

 

By: Jane Gibson
+44 20 8652 3214

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly